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Nove l  Computer  App l i ca t ions  fo r  
Card iovascu lar  Care  
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Orange County Convent ion Center, Hall E 
Presentation Hour: 9:00 a .m. -10:00 a.m. 
~ Autonomic of Poincare Plots o f  Components 
Heart Rate Variability 
Bruce D. Nearing, Julie A. Kovach, Richard I_ Verder. Institute for 
Preven~n of Cardiovascular Disease, Deaconess HospltN, Harvard 
Medical School, Boston MA; Walter Reed Army Medical Center, 
Washington DC 
Poincare plots of R-RN against R-RN+I intervals offer a simple yet powerful 
technique 1o characterize heart rate variability, do not require data stationarity, 
and are less sensitive to art;fact han spectral analysis. Heart failure patients 
exhibit a clustered, torpedo pattem which is distinct from the dispersed, 
complex pattern of normal subjects. To characterize the autonomic basis for 
these patterns, we tested the effect of beta-edrenergic (metoprolol, 1,5 mg/kg, 
i.v.) and muscadnic (glyccpyrrolate, 0.01 mg/kg, i.v.) blockade in conscious 
dogs. The patterns in the 6 dogs were: Control: 6 complex; Metoproloh 6 
fan-shaped (x 2 : 12, p < 0.05); Glyccpyrrolate: 5 tsrpedo-shaped, 1fan (X 2 
= 12, p < 0.05, ~. Example: 
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Conclusion: Autonomic blockade reveals two general Poincare plot pat- 
terns: e fan following beta-edrenergic blockade end a torpedo following 
muscarlnic blockade. The torpedo Poincare pattern of heart rate variability is 
consistent with clinical evidence of enhanced sympathetic activity in patients 
with heart failure. Thus, Poincare plot technique provides a simple, dynamic 
method for tracking autonomic function which could provide unique insights 
into neural control of the normal a~d diseased head. 
~ Improved of Cardiac Patient Data Management 
Integrated From Palmtop and Oesktop Computers 
Yzhar Charuzi, Gabriel Leonte, Michael Mesnik. Cedars.Sinai Medical 
Center, Los Angeles, California 
We are using a personal digital assistant (PDA) equipped with XT processor, 
MS-DOS 5.0 system, I Mb RAM and 10 Mb PCMCIA RAM card. Hospital 
patient (pt) data was entered into WordPedect (WP) 5.1 word processor using 
form tiles and macro programs to ensure a standard format and complete 
data set for each pt. History and physica((H&P), consultations, procedures, 
daily notes, or discharge summary can be selectively printed and immediately 
placed in the chart obviating frequently illegible handwritten otes. The PDA 
records are integrated into the office pamonal computer (PC) via a null 
modem serial interface or PCMCIA drive. The office PC holds independent 
subdirectsdes for hospital data, test results and a master tile which integrates 
all patient data. Through WP 6.0 Dos or WP 6.1 for Windows QuicT, Finder 
index, all records can be queried for a variety of subsets. 
Advantages of this system are: 1) standardization of data entry for beth 
in and outpatients 2) access to pt data independent of hospital chart 3) 
immediate printouts of hospital activities in pt chart 4) summarizing of all 
lot dal.~ into a master file 5) instantaneous recall of information 6) a copy 
of pt master fi~e together with embedded ECG and other graphic data is 
available for pts and doctors 7) accurate billing information 8) queries of PC 
sutXlirectorias allow rapid access to patient information, thereby facilitating 
decision making thus improving quality of cardiac patient care. 
~ A  Neural Network Model for Anaqlsis of  
Prognostic Factors in Congestive Heart Failure 
Donna L. Hudson, Maurice E. Cohen, Rebecca J. Kacefield, Prakash 
C. Deedwania. University of California, San Francisco, California State 
University and VA Medical Center, Fresno 
A connectionlst expert system derived from a neural network model is used to 
establish a model for prognostic factors in congestive heart failure (CHF). The 
learning algorithm was developed by the authors and utilizes a non-statistical 
approach to supervised learning. The algorithm generates a non-linear deci- 
sion surface which divides cases into two or more categories. The method 
has been applied previously to the analysis of exercise testing data (E1-1"). 
Output from the model is easy to inteqoret. An equation of the form: D(x) = £ 
w~ xL + ~: w~ xl x I is obtained. The weighting factor wl on each x~ indicates the 
relative importance of that parameter; w~ indicates the relative importance of 
the interaction of x~ and x i. Several hundred patients with congestive heart 
failure were followed. A random sample of 50 surulvlng patients were com- 
pared to a similar sample of patients who bad died. The neural network was 
run to determine possible prognostio factors. Thirteen vectors were used as a 
training set with each vector consisting of eight components: symptom status 
(decreased, stable, increased), BUN, orthopnea (y/n), dyspnea at rest (y/n), 
heart rate, edema (y/n), functional impairment (levels 1-3), PND (y/n). The 
parameters are listed in order of impo~nce, as determined by the decision 
function, Testing the decision model on the entire data sets results in the 
following measures: sensitivity: 79%, specificity: 80%, accuracy: 79%. As 
more follow-up data become available, the model will be retrained using a 
larger sample to test stability. 
~ Analysis Hoiter Data for  Indications of  o f  
Congest ive Heart Failure Using Continuous 
Chaotic Modeling 
Maurice E, Cohen, Donna L. Hudson, Prakash C. Deedwanla. University of 
California, San Franc/sco, California State University; VA Medical Center, 
Fresno, California 
A continuous approach to chaotic modeling developed by the authors has 
been used to produce second-order differenc~ :Jlots representing the rate of 
change of the heart rate variability obtained from 24-hour Holter tapes. A plot 
with low variability will have points clustered around the origin. As a means of 
quantifying these results, we developed a central tendency measure (CTM) 
which provides a rapid summary of information: 
CTM = [~2 '~(d,,]/(n - 2, 
1 il[(di+2-dl+l)2+(dl+l -di)2] 0's < r 
Z~(d~) = otherwise 
with n the total number of points, d, the time between heart beats at time 
n, and r the radius selected for analysis. A program computes second-order 
differences and CTM in one pass, with an option 1o produce graphical output 
in the form of a second-order difference plot. The processing time is under 
90 seconds for 100,000 points. Fifty-four Holler tapes were analyzed: 26 
for patients with congestive heart teitura (CHF) and 28 for normal subjects. 
Central tendencies were evaluated using r = 0.1. The mean CTM's for CHF 
(0.69) and normats (0.90) were significantly different (p < 0.01). Only two 
normals had a CTM less than 0.8, while 15 CHF subjects felt into this category. 
This method shows promise in evaluating Holler tapes as one parameter in 
the diagnosis of CHF, and may also be useful in the evaluation of other 
cardiac disorders. 
~-~ Assessing Risk and Outcome of Acute 
Myocard ia l  In fa rc t ion  
Wednesday,  March 27, 1996, Noon- -2:00 p.m. 
Orange County  Convent ion Center,  Hai l  E 
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Cutoff  for a Rapid Whole B lood Cardiac Treponln ~ 
T Assay 
Robert H. Christenson, Gladys L. Nonsozana, Show-Hong Duh, 
Luann ~.~hs. Univ. of Maryland, Baltimore, MD; Boehringer Mannheim 
Corp., Indianapolis, IN 
Elevated cardiac troponin T (cTnT) in patients with acute coronary syndromes 
(ACS) has been related to an adverse outcome, indicating that cTnT may 
be useful for tdaga and risk stratification. Because turnaround of the "Gold 
Standard" cTnT assay (ES 300; Boehdnger Mannheim Corp.) requires 1.5- 
2.0 his, we examined a binary (+/-) whole blood cTnT Rapid Assay that 
requires only 20 min by comparing its cutoff to the ES-300 assay. A positive 
cutoff el 0.2 ng/mL for the Rapid Assay was investigated using concurrent 
serum and EDTA blood specimens from 483 ACS pts. The ES-300 showed 
161 positive results (> 0.2 rig/eL) and 322 negative results (< 0.2 rag/eL); 
the Rapid Assay yielded 156 positive results while 327 pt samples were cTnT 
Rapid Assay negalive. Comparative data between the ES-300 and the Rapid 
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Assay are as shown (PPV = Pos, Predictive Value; NPV = Nag. Predictive 
Value): 
Cor¢ord~nt Discordant Sans. Spe¢. PPV NPV 
Resulm Resur~ 
(95.2%) 23 [4.B%) 97.2% 91.3% 9.4.2% 95.~ 
Using the McNemar test, we found that the cutoff or the cTnT Rapid Assay 
was not significantly different (p = 0.40) from the specified 0.2 ng/mL ES-300 
vatue for a hypothesis of 95"/,, confidenoe. 
Use of the cTnT Rapid Assay In Idage or risk stratification strategies is 
promising because it uses EDTA whole blood, requires only 20 rain, and has 
a O.R ng/mL cutoff that ¢oweietas well with the established quantitative ssay 
used in other studies. 
~ The Value of  Bedside Troponin T Testing in the 
Emergency Room for Risk Str~itlaation in 
Patients With Chest Pain After Discharge From 
Hospits l  
Bdtta U, Gotdmann. Chdstian W. Harem, Jan C. Schneider. Gescho M. VoB. 
Thomas Meinellz, Un/vers/fy Hospital Eppendoff, Dept. of Cardiol~, 
Hamburg, Germany 
The value of a newly developed bedside assay for trOponln T (l"nT) mea- 
surements to predict coronary heart disease was recently demonslra~ad. 
We investigated, whether early bedside lroponin T measurements in the 
emergency room are also useful for risk stratification in pts with suspected 
tschemio heart disease after discharge from hospital. We screened n = 236 
pts (male/female 141/95, age 63 4- 15) presenting to the emorge~'cy room 
for the mason of acute chest pain 7 + 5 hrs after onset of symptoms. Cardiac 
TnT was determined semi-quantitatively ad admission and after a six houm 
interval Pts. with at least one positive test result were considered TnT pos- 
itive. All pts were followed for one month after discharge from the hospital 
to record cardiac events (AMI, death) or the need for further interventions 
(coronary angloplasty: PTCA, bypass surgery: AGVB). 
Results: 1 month follow-ap aftsr discharge: 
TnT pos~thre TnT he.rive p value 
n~47 n = 18"Z 
I~ath e (1 ~P~) 2 (1%) <0.01 
AMI 12 (26%) 2 (1%) <0.01 
AC',/B 1 (2%) 2 (1%) n.s. 
PTGA 3 (13%) . . . .  9(S%) n.s. 
NI events occured after discharge from hospital. Cause of death in the 
TnT negative group in two pts. was stroke and cerebral neopl~m. Two pts. 
in the TnT negative group developed myocardial infarction after exclusion of 
AMI 1 month before. 
Condu~bn: The 0resent msuilS suggest that mp~d TnT meesumments 
in the emergency room may allow eady risk slretif~:~tion and prediction of 
cardiac events after discharge in pts with suspected coronary heart disease. 
~ L o w  Weight Heparin (I)altepadn) Molecular In the 
Management of Unstable Coronary Artery 
Disease (FRIC) 
W. Klein for the FRIC Study Group. Austria, Canada, Germany, Italy, 
Norway, The Netherlands, Spain. Unfted Kingdom, Unit~ Stetes 
Asp|fin and heparin reduce the risk of ischaemtc events including death and 
MI in unstable CAD, bUt reactivation may occur when hopadn Is discon- 
tinued. Low moleu-ular weight heparins (LWMH) have pharmacological nd 
phan~lkokinetlc prepares that may improve entithmmbeti~ therapy and at- 
low long-term tmatmanL The FRIO study 13 a multi-centre •al In patients 
with unstable CAD receiving aspirin and conventional antlanglnal trealment 
who were openlY randomized to LMWH (daltoparin) 120 IU/kg b.w. 12-houW 
~C or ]V-hapafln followed by SC heparin (APTT 1.5-2,0 X control) for 5-8 
days during hospitalization. In a long-term tmetmenl comparison, patients 
received eith:, dalteparin (7500 IU/day) or placebo SO for 40 days acoording 
to a double-blind random allocation at enW to the trial. The primary objective 
of the study was to determine the efficacy and safety of daltepadn In reduc- 
ing death, MI and recuwence of angina between day 6 and 45. Secandapj 
outcomes were death, MI, recurrent angina or revas~ularization during the 
~mndap/Oulcon'~z Daftapar/n Heparfn p 
(D.._a!m 5-8) % . . . . .  (n = 751 ) (.n -731) 
Reva~u~dz~t[on 5.2 5.8 0.48 
Oeath~ti/l:teeumsnt A gina/Revazcularlzallo n 13.0 12.5 0,99 
~ . o r ~ m  . . . . .  0 .3 . , .o  . .  
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hosp'dat phase. 1500 patients were recru/ted and the data from the I~osp~,~l 
phase are shown in the table. 
"/'he data show no d~erence In the incidence of ischaemi¢ events and 
in safety between the ~vo ffeatments in the hospital phase. Ccmpafisen of 
the I~imery outcomes between the two tmam~nt groups at day 45 will be 
presented. 
~ Braunwald Anginal Class as Risk Factor for the 
Oecummce o l  Early and Late Clinical Events 
Following Comne~ AngloplaMy (PTCA) for  
Unstable Angina Pectoris (UAP) 
Jean-Paul R. Herrman, Rein Meiked, Ke~h Fox 1, Patdck W. Sen'Ws on 
behaff of the HELVETICA investigators. 1The Un/vers//y of Edinburgh, 
Edinburgh, United Kingdom; Thoraxcentre, Erasmus Universe, Rotterdam, 
theNethedarx~ 
Background: Clinical events such as death, myocardial interc~on (MI), bail- 
out, bypass surgery (GABG) and re-PTGA hamper early and late outcome of 
PTCA. This ancillary study thvestigated the effect of the severity of UAP on 
eady and late adverse clin'¢at outcome (occumng within 4 or 210 dsylS). 
Methods: The studied population enrbled prospec~vely the HELVETICA 
study, in whk;h recombinant •rudin (HIq i.v. or Lv. + s.c. was compared to 
hepafin (Hap) tmatmenL Bfaunwald's classif'¢etion lEG) for UAP was used. 
~C I: New onset or accelerated AP, no rest pain. BC I1: AP at rest within the 
past month, BC Ill: AP at rest within the preceding 48 hours. 
Results: The table presents the percentage of patients experiendng early 
or late clinical events per Bmurmrald class and per tmathtont group or total 
pepulation. 
Eady events Late events 
Treatn~nt Hit Hir Hap Total H/r Hit Hap Total 
iv+sc iv iv+sc iv 
N - .'178 381 382 1141 378 381 382 1141 
BC I 3,6 8.9 4.6 5.8 24.5 90.8 22.9 27.4 
(N" 416) 
BC II 4-2 8.1 10.4 7,6 34.9 39.4 39.3 37.3 
(N " 489) 
8C II! t2.3 5.3 21.6 13,6 39,7 41.3 35.2 38.6 
(N-236) 
P 0.02 NS 0.00 0.00 0.04 NS NS 0,00 
(N? 416) . . . . .  
Con(fusion: Incroa~_ severity Of unstable angina results in an overall 
sig~ifican~ increased sk for the oocunenca of ea,'ty and Icte clinical events. 
~ Impsct of  Patient Delay and Thrombolytle 
Trealment on Mortal ity Among 5978 Patients With 
Acute Myoca~llal  Infar¢l lon 
MiChael OtteSen, Lars K~ber, Christian Torp-Pedersen. Department of 
CaraWay, C, ento~e University HoCk.  DenmarX 
Background: lime from onset of symptoms of acute myocardial infamtfon 
(AMI) until admission in ~ is extremely important, as the greatest 
dsk of death is within the first hours. Time from onset of symptoms until 
administration o1 thmmlytic therapy (Tt') is deten-dnsnt oi its efficiency in 
reducing morbidity and mo~lity. 
Nm: To assess the impact of paliont delay on short- and Iong-temq mort~ity 
following AML 
Methods: 6676 consecutive cases ot AM1 were adz~1ed in 27 centers 
in Oenmad~ from May 1990 to June 1992, Baseline cheractadstica, p l~nt 
delay and Ueetment was registered. Data on ~r~l@ were ~¢ed tn~ 
Oonish Ce~x'~I Fo~onal Register on the 15th July 1994. Patients were 
etmtified accoc~ig to dalw into threa groups I) deiay< 2 houm (n = 2039), 
2) delay 2-6 hours (n - 2049) and 3) delay > 6 hours (n = 1890). 
Results: In 5978 (89.5%) cases infom~tion on paUent debzy was mrsilable. 
Mean delay 9,1 houm and median delay 3.25 bourn, 2512 (42.0%) patients 
were mceivIn9 TI", Six d~y sun~'al rate was 95% in group 1,94% in group 2 
and 3 (N,~). The one, two and thrse year sundvat rates were 82%, 75% and 
70% In group 1, 79%, 72% and 66% th group 2, aed 73%, 67% and 60% 
~n group 3Lo < o.o~), sy camp~ pa~ie~s who received TT, to those who 
did not. it was shown that the difference between the three gmupa In suntival 
~es  en(y wes observed eatong i~llents who received T~. One, ~o  and 
threa year survlval ratss were 88%, 84% end 80% In group I, 84%, 79% and 
"/3% in ~oup 2, aad 81%, T/% and 73% th group 3 for those who n~mcl  
For thosa who dld not mseive TT, o~,  ~o and three ysar survival rates 
w~e 74%, 65% and 58% In greup l, 72%o S4% and S"i% in gm~ 2, and 
71%, 64% end 57% (n group 3, Them was slgnificanl dllterenoe in sunmra 
rates betwean the three groupa arrmng patients who rsceived TT {p < 0.01 ), 
but not when patients for various reasons were denied Tr. 
Conclusion: Patient delay In patients admitted alive with an AMI had no 
